Concepedia

Author

Clare Morgan

Royal College of Surgeons in Ireland

Also Known As

C Morgan, C. Morgan, Clare Morgan, Clare P. Morgan, Morgan, Clare

33

Publications

332

Citations

11

H-Index

8

Concepts

All Affiliations

Royal College of Surgeons in IrelandBeaumont HospitalSt. Vincent's University HospitalSt. James's HospitalDublin City University
CM

About

Clare Morgan is an author at Royal College of Surgeons in Ireland specializing in oncology, cancer therapeutics, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

48

2

Cell Biology

1

1

48

3

Cancer Therapeutics

1

1

48

4

Systems Biology

1

1

48

5

Breast Cancer

1

1

48

Clare Morgan

×

11

Publications

300

Citations

11

H-Index

YearCitations

BCL-2 system analysis identifies high-risk colorectal cancer patients

Andreas U. Lindner, Manuela Salvucci, Clare Morgan,

Gut

2016

52

A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinib

Naomi Elster, Mattia Cremona, Clare Morgan,

Breast Cancer Research and Treatment

2014

48

Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer

M. Janusz Mezynski, Angela M. Farrelly, Mattia Cremona,

Journal of Translational Medicine

2021

37

Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer

Alexandra Canonici, Alacoque L. Browne, Mohamed Ibrahim,

Therapeutic Advances in Medical Oncology

2020

33

A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer

Manuela Salvucci, Maximilian L. Würstle, Clare Morgan,

Clinical Cancer Research

2016

27

A preclinical evaluation of the MEK inhibitor refametinib in HER2-positive breast cancer cell lines including those with acquired resistance to trastuzumab or lapatinib

John J. O’Shea, Mattia Cremona, Clare Morgan,

Oncotarget

2017

21

Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro

Ozlem Aslan, Mattia Cremona, Clare Morgan,

BMC Cancer

2018

21

Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples

Sinéad Toomey, Aoife Carr, M. Janusz Mezynski,

Journal of Translational Medicine

2020

18

Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers

Małgorzata Milewska, Mattia Cremona, Clare Morgan,

Therapeutic Advances in Medical Oncology

2018

15

BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors

Mattia Cremona, Cassandra J. Vandenberg, Angela M. Farrelly,

British Journal of Cancer

2022

15

Page 1